Anti-atherogenic effect of coenzyme Q10 in apolipoprotein E gene knockout mice

Free Radical Biology and Medicine

Volumn 29, Issue 3-4, 2000, Pages 295-305

  Witting, Paul K ^a   Stocker, Roland ^a,b   Letters, Jacinta ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Antioxidants; Apolipoprotein E gene knockout mouse; Atherosclerosis; Free radicals; Lipoprotein lipid peroxidation; Ubiquinol; Ubiquinone

Indexed keywords

APOLIPOPROTEIN E; UBIDECARENONE;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG EFFECT; KNOCKOUT MOUSE; LIPID OXIDATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; RODENTIA;

EID: 0033805295     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00311-7     Document Type: Article

References (73)

1. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol modifications of low-density lipoprotein that increase its atherogenicity . N. Engl. J. Med. 320:1989;915-924.
2. Ylä-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., Witztum J.L., Steinberg D. Evidence for the presence of oxidatively modified low-density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1989;1086-1095.
3. Hoff H.F., O'Neil J., Pepin J.M., Cole T.B. Macrophage uptake of cholesterol-containing particles derived from LDL and isolated from atherosclerotic lesions. Eur. Heart J. 11:(Suppl. E):1990;105-115.
4. Steinbrecher U.P., Lougheed M. Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low-density lipoprotein extracted from human aortic intima. Arterioscler. Thromb. 12:1992;608-625.
5. Hazell L.J., Arnold L., Flowers D., Waeg G., Malle E., Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97:1996;1535-1544.
6. Hazen S.L., Heinecke J.W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low-density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99:1997;2075-2081.
7. Smith E.B., Slater R.S. The chemical and immunological assay of low-density lipoprotein extracted from human aortic intima. Atherosclerosis. 11:1970;417-438.
8. Carpenter K.L.H., Taylor S.E., Ballantine J.A., Fussell B., Halliwell B., Mitchinson M.J. Lipids and oxidized lipids in human atheroma and normal aorta. Biochim. Biophys. Acta. 1167:1993;121-130.
9. Suarna C., Dean R.T., May J., Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate. Arterioscler. Thromb. Vasc. Biol. 15:1995;1616-1624.
10. Niu X., Zammit V., Upston J.M., Dean R.T., Stocker R. Coexistence of oxidized lipids and α-tocopherol in all lipoprotein fractions isolated from advanced human atherosclerotic plaques. Arterioscl. Thromb. Vasc. Biol. 19:1999;1708-1718.
11. Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20:1996;707-727.
12. Kokkonen J.O., Kovanen P.T. Proteolytic enzymes of mast cell granules degrade low-density lipoproteins and promote their granule-mediated uptake by macrophages in vitro. J. Biol. Chem. 264:1989;10749-10755.
13. Schissel S.L., Jiang X., Tweedie-Hardman J., Jeong T., Camejo E.H., Najib J., Rapp J.H., Williams K.J., Tabas I. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J. Biol. Chem. 273:1998;2738-2746.
14. Hurt-Camejo E., Camejo G., Rosengren B., Lopez F., Ahlstrom C., Fager G., Bondjers G. Effect of arterial proteoglycans and glycosaminoglycans on low-density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler. Thromb. 12:1992;569-583.
15. Pentikainen M.O., Lehtonen E.M., Oorni K., Lusa S., Somerharju P., Jauhiainen M., Kovanen P.T. Human arterial proteoglycans increase the rate of proteolytic fusion of low-density lipoprotein particles. J. Biol. Chem. 272:1997;25283-25288.
16. Steinbrecher U.P., Lougheed M., Kwan W.-C., Dirks M. Recognition of oxidized low-density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. J. Biol. Chem. 264:1989;15216-15223.
17. Upston J.M., Terentis A.C., Stocker R. Tocopherol-mediated peroxidation (TMP) of lipoproteins implications for vitamin E as a potential antiatherogenic supplement . FASEB J. 13:1999;977-994.
18. Parthasarathy S., Young S.G., Witztum J.L., Pittman R.C., Steinberg D. Probucol inhibits oxidative modification of low-density lipoprotein. J. Clin. Invest. 77:1986;641-644.
19. Björkhem I., Henriksson-Freyschuss A., Breuer O., Diczfalusy U., Berglund L., Henriksson P. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler. Thromb. 11:1991;15-22.
20. Sparrow C.P., Doebber T.W., Olszewski J., Wu M.S., Ventre J., Stevens K.A., Chao Y.S. Low-density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine. J. Clin. Invest. 89:1992;1885-1891.
21. Cynshi O., Kawabe Y., Suzuki T., Takashima Y., Kaise H., Nakamura M., Ohba Y., Kato Y., Tamura K., Hayasaka A., Higashida A., Sakaguchi H., Takeya M., Takahashi K., Inoue K., Noguchi N., Niki E., Kodama T. Anti-atherogenic effects of the antioxidant BO-653 in three different animal models. Proc. Natl. Acad. Sci. USA. 95:1998;10123-10128.
22. Witting P.K., Pettersson K., Östlund-Lindqvist A.-M., Westerlund C., Westin Eriksson A., Stocker R. Inhibition by a co-antioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low-density lipoprotein receptor gene double knockout mice. FASEB J. 13:1999;667-675.
23. Mao S.J., Yates M.T., Rechtin A.E., Jackson R.L., Van-Sickle W.A. Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits. J. Med. Chem. 34:1991;298-302.
24. Fruebis J., Steinberg D., Dresel H.A., Carew T.A. A comparison of the anti-atherogenic effects of probucol and a structural analogue of probucol in low-density lipoprotein receptor-deficient rabbits. J. Clin. Invest. 94:1994;392-398.
25. Witting P.K., Pettersson K., Östlund-Lindqvist A.-M., Westerlund C., Wågberg M., Stocker R. Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits. J. Clin. Invest. 104:1999;213-220.
26. Beyer R.E., Nordenbrand K., Ernster L. The function of coenzyme Q in free radical production and as an antioxidant a review . Chem. Scripta. 27:1987;145-153.
27. Thomas S.R., Witting P.K., Stocker R. A role for reduced coenzyme Q in atherosclerosis? BioFactors. 9:1999;207-224.
28. Stocker R., Bowry V.W., Frei B. Ubiquinol-10 protects human low-density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc. Natl. Acad. Sci. USA. 88:1991;1646-1650.
29. Frei B., Kim M., Ames B.N. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc. Natl. Acad. Sci. USA. 87:1990;4879-4883.
30. Kagan V.E., Serbinova E.A., Koynova G.M., Kitanova S.A., Tyurin V.A., Stoytchev T.S., Quinn P.J., Packer L. Antioxidant action of ubiquinol homologues with different isoprenoid chain length in biomembranes. Free Radic. Biol. Med. 9:1990;117-126.
31. Mukai K., Kikuchi S., Urano S. Stopped-flow kinetic study of the regeneration reaction of tocopheroxyl radical by reduced ubiquinone-10 in solution. Biochim. Biophys. Acta. 1035:1990;77-82.
32. Kagan V., Serbinova E., Packer L. Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling. Biochem. Biophys. Res. Commun. 169:1990;851-857.
33. Bowry V.W., Stocker R. Tocopherol-mediated peroxidation. The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J. Am. Chem. Soc. 115:1993;6029-6044.
34. Mohr D., Bowry V.W., Stocker R. Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation. Biochim. Biophys. Acta. 1126:1992;247-254.
35. Mohr D., Umeda Y., Redgrave T.G., Stocker R. Antioxidant defenses in rat intestine and mesenteric lymph. Redox Report. 4:1999;79-87.
36. Palinski W., Ord V.A., Plump A.S., Breslow J.L., Steinberg D., Witztum J.L. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titres of autoantibodies to malondialdehyde-lysine in serum. Arterioscler. Thromb. 14:1994;605-616.
37. Hayek T., Oiknine J., Brook J.G., Aviram M. Increased plasma and lipoprotein lipid peroxidation in apoE-deficient mice. Biochem. Biophys. Res. Commun. 201:1994;1567-1574.
38. Aviram M., Maor I., Keidar S., Hayek T., Oiknine J., Bar E.L.-Y., Adler Z., Kertzman V., Milo S. Lesioned low-density lipoprotein in atherosclerotic apolipoprotein E-deficient transgenic mice and in humans is oxidized and aggregated. Biochem. Biophys. Res. Commun. 216:1995;501-513.
39. Letters J.M., Christison J.K., Witting P.K., Westin Eriksson A., Pettersson K., Stocker R. Changes to lipids and antioxidants in plasma and aortae of apoE-deficient mice. J. Lipid Res. 40:1999;1104-1112.
40. Yamamoto Y., Ames B.N. Detection of lipid hydroperoxides and hydrogen peroxide at picomole levels by an HPLC and isoluminol chemiluminescence assay. Free Radic. Biol. Med. 3:1987;359-361.
41. Buettner G.R. Use of ascorbate as test for catalytic metals in simple buffers. Methods Enzymol. 186:1990;125-127.
42. Piedrahita J.A., Zhang S.H., Hagaman J.R., Oliver P.M., Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 89:1992;4471-4475.
43. Witting P.K., Mohr D., Stocker R. Assessment of pro- and antioxidant activity of vitamin E in human low-density lipoprotein and plasma. Methods Enzymol. 299:1998;362-375.
44. Thomas S.R., Neuzil J., Stocker R. Cosupplementation with coenzyme Q prevents the pro-oxidant effect of α-tocopherol and increases the resistance of low-density lipoprotein towards transition metal-dependent oxidation initiation. Arterioscl. Thromb. Vasc. Biol. 16:1996;687-696.
45. Neuzil J., Thomas S.R., Stocker R. Requirement for, promotion, or inhibition by α-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation. Free Radic. Biol. Med. 22:1997;57-71.
46. Sattler W., Mohr D., Stocker R. Rapid isolation of lipoproteins and assessment of their peroxidation by HPLC postcolumn chemiluminescence. Methods Enzymol. 233:1994;469-489.
47. Neuzil J., Christison J.K., Iheanacho E., Fragonas J.-C., Zammit V., Hunt N.H., Stocker R. Radical-induced lipoprotein and plasma lipid oxidation in normal and apolipoprotein E gene knockout (apoE-/-) mice. ApoE-/- mouse as a model for testing the role of tocopherol-mediated peroxidation in atherogenesis. J. Lipid Res. 39:1998;354-368.
48. Frei B., Yamamoto Y., Niclas D., Ames B.N. Evaluation of an isoluminol chemiluminescence assay for the detection of hydroperoxides in human blood plasma. Anal. Biochem. 175:1988;120-130.
49. Barclay L.R.C., Locke S.J., MacNeil J.M., VanKessel J. Autoxidation of micelles and model membranes. Quantitative kinetic measurements can be made by using either water-soluble or lipid-soluble initiators with water-soluble or lipid-soluble chain-breaking antioxidants. J. Am. Chem. Soc. 106:1984;2479-2481.
50. Mach F., Schonbeck U., Sukhova G.K., Atkinson E., Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature. 394:1998;200-203.
51. Elmberger P.G., Kalén A., Brunk U.T., Dallner G. Discharge of newly synthesized dolichol and ubiquinone with lipoproteins to rat liver perfusate and to the bile. Lipids. 24:1989;919-930.
52. Zhang Y., Aberg F., Appelkvist E.-L., Dallner G., Ernster L. Uptake of dietary coenzyme Q supplement is limited in rats. J. Nutr. 125:1995;446-453.
53. Lass A., Forster M.J., Sohal R.S. Effects of coenzyme Q10 and α-tocopherol administration on their tissue levels in the mouse elevation of mitochondrial α-tocopherol by coenzyme Q10 . Free Radic. Biol. Med. 26:1999;1375-1382.
54. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14:1994;133-140.
55. Zhang S.H., Reddick R.L., Avdievich E., Surles L.K., Jones R.G., Reynolds J.B., Quarfordt S.H., Maeda N. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice. J. Clin. Invest. 99:1997;2858-2866.
56. Mohr D., Stocker R. Radical-mediated oxidation of isolated human very low-density lipoprotein. Arterioscl. Thromb. 14:1994;1186-1192.
57. 10 and vitamin E on the peroxidation of human low-density lipoprotein subfractions. Proc. Natl. Acad. Sci. USA. 92:1995;9388-9391.
58. Heinecke J.W. Oxidants and antioxidants in the pathogenesis of atherosclerosis implications for the oxidized low-density lipoprotein hypothesis . Atherosclerosis. 141:1998;1-15.
59. Åberg F., Appelkvist E.L., Dallner G., Ernster L. Distribution and redox state of ubiquinones in rat and human tissues. Arch. Biochem. Biophys. 295:1992;230-234.
60. Maiorino M., Thomas J.P., Girotti A.W., Ursini F. Reactivity of phospholipid hydroperoxide glutathione peroxidase with membrane and lipoprotein lipid hydroperoxides. Free Radic. Res. Commun. 12-13:1991;131-135.
61. Sattler W., Christison J.K., Stocker R. Cholesterylester hydroperoxide-reducing activity associated with isolated high- and low-density lipoproteins. Free Radic. Biol. Med. 18:1995;421-429.
62. Garner B., Waldeck A.R., Witting P.K., Rye K.-A., Stocker R. Oxidation of high-density lipoproteins. II. Evidence for direct reduction of HDL lipid hydroperoxides by methionine residues of apolipoproteins AI and AII. J. Biol. Chem. 273:1998;6088-6095.
63. Mashima R., Yamamoto Y., Yoshimura S. Reduction of phosphatidylcholine hydroperoxide by apolipoprotein A-I purification of the hydroperoxide-reducing proteins from human blood plasma . J. Lipid Res. 39:1998;1133-1140.
64. Kuhn H., Belkner J., Wiesner R., Brash A.R. Oxygenation of biological membranes by the pure reticulocyte lipoxygenase. J. Biol. Chem. 265:1990;18351-18361.
65. Pratico D., Tangirala R.K., Radar D., Rokach J., FitzGerald G.A. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice. Nature Med. 4:1998;1189-1192.
66. Yokoyama H., Lingle D.M., Crestanello J.A., Kamelgard J., Kott B.R., Momeni R., Millili J., Mortensen S.A., Whitman G.J. Coenzyme Q10 protects coronary endothelial function from ischemia reperfusion injury via an antioxidant effect. Surgery. 120:1996;189-196.
67. Lonnrot K., Porsti I., Alho H., Wu X., Hervonen A., Tolvanen J.P. Control of arterial tone after long-term coenzyme Q10 supplementation in senescent rats. Br. J. Pharmacol. 124:1998;1500-1506.
68. Cooke J.P., Singer A.H., Tsao P.S., Zera P., Rowan R.A., Billingham M.E. Anti-atherogenic effects of L-arginine in the hypercholesterolemic rabbit. J. Clin. Invest. 90:1992;1168-1172.
69. Niibori K., Yokoyama H., Crestanello J.A., Whitman G.J. Acute administration of liposomal coenzyme Q10 increases myocardial tissue levels and improves tolerance to ischemia reperfusion injury. J. Surg. Res. 79:1998;141-145.
70. Lopez-Lluch G., Barroso M.P., Martin S.F., Fernandez-Ayala D.J., Gómez-Díaz C., Villalba J.M., Navas P. Role of plasma membrane coenzyme Q on the regulation of apoptosis. Biofactors. 9:1999;171-177.
71. Hano O., Thompson Gorman S.L., Zweier J.L., Lakatta E.G. Coenzyme Q10 enhances cardiac functional and metabolic recovery and reduces Ca2+ overload during postischemic reperfusion. Am. J. Physiol. 266:1994;H2174-H2181.
72. Langsjoen P.H., Langsjoen A.M. Overview of the use of CoQ10 in cardiovascular disease. Biofactors. 9:1999;273-284.
73. Gómez-Díaz C., Rodríguez-Aguilera J.C., Barroso M.P., Villalba J.M., Navarro F., Crane F.L., Navas P. Antioxidant ascorbate is stabilized by NADH-coenzyme Q10 reductase in the plasma membrane. J. Bioenerg. Biomembr. 29:1997;251-257.